Apyx Medical (APYX) Equity Ratio (2010 - 2026)

Apyx Medical has reported Equity Ratio for 17 years, with the latest figure at 0.2 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio rose 15.08% year-over-year to 0.2; the trailing twelve-month figure through Mar 2026 stood at 0.2 (up 15.08% YoY), and the FY2025 full-year result was 0.22, down 1.6% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.2, down from 0.22 in the prior quarter.
• The five-year high for Equity Ratio was 0.79 in Q1 2022, with the low at 0.11 in Q3 2025.
• Historically, Equity Ratio has averaged 0.41 across 5 years, with a median of 0.29 in 2024.
• Annual changes were most pronounced in 2024 — Equity Ratio slumped 67.36% — and 2026, when it gained 15.08%.
• Apyx Medical's Equity Ratio stood at 0.73 in 2022, then slumped by 53.46% to 0.34 in 2023, then tumbled by 34.93% to 0.22 in 2024, then retreated by 1.6% to 0.22 in 2025, then retreated by 6.4% to 0.2 in 2026.
• The last three Equity Ratio figures came in at 0.2 (Q1 2026), 0.22 (Q4 2025), and 0.11 (Q3 2025), per Business Quant data.